Combining DNA damaging agents and checkpoint 1 inhibitors

Current Medicinal Chemistry - Anti-Cancer Agents

Volumn 4, Issue 5, 2004, Pages 435-438

  Prudhomme, Michelle ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 13 HYDROXY 15 OXOZOAPATLIN; 7 ETHYL 10 HYDROXYCAMPTOTHECIN; 7 HYDROXYSTAUROSPORINE; ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; CAFFEINE; CEP 3891; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CISPLATIN; DEBROMOHYMEDIALDISINE; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; GRANULATIMIDE; HYDROXYUREA; ICP 1; IRINOTECAN; ISOGRANULATIMIDE; KARENITECIN; MITOMYCIN C; PD 0166285; PHOSPHOTRANSFERASE; PROTEIN P53; SB 218078; STAUROSPORINE; UNCLASSIFIED DRUG;

CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CYTOTOXICITY; DNA ALKYLATION; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DRUG MECHANISM; ENZYME INHIBITION; GENE MUTATION; MITOSIS; NONHUMAN; REVIEW;

ANTINEOPLASTIC AGENTS; DNA; DNA DAMAGE; G1 PHASE; G2 PHASE; GENES, P53; HUMANS; HYDROXYUREA; INHIBITORY CONCENTRATION 50; MITOSIS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; MUTATION;

EID: 4444228258     PISSN: 15680118     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568011043352795     Document Type: Review

References (35)

1. Chen, Z.; Xiao, Z.; Chen, J.; Ng, S.-C.; Sowin, T.; Sham, H.; Rosenberg, S.; Fesik, S.; Zhang, H. Molecular Cancer Therapeutics, 2001, 2, 543.
2. Bartek, J.; Lukas, J. Cancer Cell, 2003, 3, 421.
3. Hirao, A.; Kong, Y.Y.; Matsuoka, S.; Wakeham, A.; Ruland, J.; Yoshida, H.; Liu, D.; Elledge, S.J.; Mak, T.W. Science, 2000, 287, 1824.
4. Bartek, J.; Lukas, J. Curr. Opin. Cell Biol., 2001, 13, 738.
5. Tenzer, A.; Pruschy, M. Curr. Med. Chem. - Anti-Cancer Agents, 2003, 3, 35.
6. Nyberg, K.A.; Michelson, R.J.; Putnam, C.W.; Weinert, T.A. Annu. Rev. Genet., 2002, 36, 617.
7. Zhou, B.-B.; Bartek, J. Nature, 2004, 4, 216.
8. Falck, J.; Mailand, N.; Syljuasen, R.G.; Bartek, J.; Lukas, J. Nature, 2001, 410, 842.
9. Anderson, H.J.; Andersen, R.J.; Roberge, M. Progress in Cell Cycle Research, (Meijer, L, Jézéquel, A, and Roberge, M, eds), 2003, 5, 423.
10. Wang, Q.; Fan, S.; Eastman, A.; Worland, P.J.; Sausville, E.A.; O'Connor, P.M. J. Natl. Cancer Inst., 1996, 88, 956.
11. Monks, A.; Harris, E.D.; Vaigro-Wolff, A.; Hose, C.D.; Connelly, J.W.; Sausville, E. Invest. New Drugs, 2000, 18, 95.
12. Kohn, E.A.; Yoo, C.J.; Eastman, A. Cancer Res., 2003, 63, 31.
13. Eastman, A.; Kohn, E.A.; Brown, M.K.; Rathman, J.; Livingstone, M.; Blank, D.H.; Gribble, G.W. Mol. Cancer Ther., 2002, 1, 1067.
14. Wang, Y.; Li, J.; Booher, R.N.; Kraker, A.; Laurence, T.; Leopold, W.R.; Sun, Y. Cancer Res., 2001, 61, 8211.
15. Kawabe, T. Mol. Cancer Ther., 2004, 3, 513
16. Hall-Jackson, C.A.; Cross, D.E.A.; Morrice, N.; Smythe, C. Oncogene, 1999, 18, 6707.
17. Sarkaria, J.N.; Busby, E.C.; Tibbets, R.S.; Roos, P.; Taya, Y.; Karnitz, L.M.; Abraham, R.T. Cancer Res., 1999, 59, 4375.
18. Busby, E.C.; Leistritz, R.T.; Karnitz, L.M.; Sarkaria, J.N. Cancer Res., 2000, 60, 2108.
19. Fuse, E.; Tanii, H.; Kurata, N.; Kobayashi, H.; Shimada, Y.; Tamura, T.; Sasaki, Y.; Tanigawara, Y.; Lush, R.D.; Headlee, D.; Figg, W.D.; Arbuck, S.G.; Senderowicz, A.M.; Sausville, E.A.; Akinaga, S.; Kuwabara, T.; Kobayashi, S. Cancer Res., 1998, 58, 3248.
20. Sausville, E.A.; Arbuck, S.G.; Messman, R.; Headlee, D.; Lush, R.D.; Bauer, K.; Murgo, A.; Figg, W.D.; Lahusen, T.; Jaken, S.; Jiang, X.; Roberge, M.; Fuse, E.; Kuwubara, T.; Senderowicz, A.M. J. Clin. Oncol., 2001, 19, 2319.
21. Mizuno, K.; Saido, T.C.; Ohno, S.; Tamaoki, T.; Suzuki, K. FEBS Lett., 1993, 330, 114.
22. Sorensen, C. S.; Syljuasen, R.G.; Falck, J.; Schroeder, T.; Rönnstrand, L.; Khanna, K.K.; Zhou, B.-B.; Bartek, J.; Lukas, J. Cancer Cell, 2003, 3, 247.
23. Jackson, J.R.; Gilmartin, A.; Imburgia, C.; Winkler, J.D.; Marshall, L.A.; Roshak, A. Cancer Res., 2000, 60, 566.
24. Yin, M.-B.; Hapke, G.; Guo, B.; Azrak, R.G.; Frank, C.; Rustum, Y.M. Oncogene, 2001, 20, 5249.
25. Curman, D.; Cinel, B.; Williams, D.E.; Rundle, N.; Block, W.D.; Goodarzi, A.A.; Hutchins, J.R.; Clarke, P.R.; Zhou, B.-B.; Lees-Miller, S.P.; Andersen, R.J.; Roberge, M. J. Biol. Chem., 2001, 276, 17914.
26. Suganuma, M.; Kawabe, T.; Hori, H.; Funabiki, T.; Okamoto, T. Cancer Res., 1999, 59, 5887.
27. Yu, Q.; La Rose, J.; Zhang, H.; Takemura, H.; Kohn, K.W.; Pommier, Y. Cancer Res., 2002, 62, 5743.
28. Rundle, N.T.; Xu, L.; Andersen, R.J.; Roberge, M. J. Biol. Chem., 2001, 276, 48231.
29. Roberge, M.; Berlinck R.G.S.; Xu, L.; Anderson, H.J.; Lim, L.Y.; Curman, D.; Stringer, C.M.; Friend, S.H.; Davies, P.; Vincent, I.; Haggarty, S.J.; Kelly, M.T.; Britton, R.; Piers, E.; Andersen, R.J. Cancer Res., 1998, 58, 5701.
30. Berlinck R.G.S.; Britton, R.; Piers, E.; Lim, L.Y.; Roberge, M.; Moreira da Rocha, R.; Andersen, R.J. J. Org. Chem., 1998, 63, 9850.
31. Andersen, R.J.; Roberge, M.; Sanghera, J.; Leung, D. International Patent, 1999, WO99/47522 ; CA 131: 243451.
32. Senderowicz A.M. Cancer Biol. Ther., 2003, 2, S84.
33. Menoyo, A.; Alazzouzi, H.; Espin, E.; Armengol, M.; Yamamoto, H.; Schwartz, S. Cancer Res., 2001, 61, 7727.
34. Pommier, Y.; Redon, C.; Rao, V.A.; Seiler, J.A.; Sordet, O.; Takemura, H.; Anthony, S.; Meng L-H.; Liao, Z-Y.; Kohlhagen, G.; Zhang, H-L.; Kohn, K.W. Mutation Res., 2003, 532, 173.
35. Chène, P. Curr.Med. Chem. - Anti-Cancer Agents, 2001, 1, 151.